Maximus wrote:What do you expect?
these are US, UK and German pharmaceutical companies,
Of course, the respective governments are going to look after their own first.
On top of that, they are private companies and they have to make a profit.
it wont be until there is excess supply before other countries can get their hands on them.
There is also a Russian and Chinese vaccine and some other countries, notably India are on the verge of completing their own.
AZ (a UK/Swedish corporation, ironically run by a Frenchman) is planning to produce a third of its 3 billion doses in an institute near Mumbai. Virtually all of that's destined for India and the developing world. The idea that they're favouring the UK and US over the EU's got no substance in reality. It's down to contractual commitments and the EU's slowness to move whilst generally screwing it up. They were hedging their bets, hopeful of ending up with the French Sanofi vaccine but they haven't been able to deliver the product.
AZ are not making a profit (unlike Pfizer/BioNTech) but producing the Covid vaccine at cost.
These companies have managed to produce viable vaccines in a fraction of the time it traditionally takes and should be applauded for that. Not publicly humiliated by a bunch of incompetent Brussels Eurocrats looking to disguise their screw-ups with a scapegoat.
That speed of delivery has been greatly assisted by preemptive research carried out into the potential of zoonotic viruses.
